
Company valuation, historical trends, and peer comparisons.
According to Amneal Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.76B. This represents a change of 46.64% compared to the average of 6.65B of the last 4 quarters.
The mean historical Enterprise Value of Amneal Pharmaceuticals, Inc. over the last ten years is 3.93B. The current 9.76B Enterprise Value has changed 148.47% with respect to the historical average. Over the past ten years (40 quarters), AMRX's Enterprise Value was at its highest in in the June 2026 quarter at 8.19B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
3.93B
Median
3.51B
Minimum
3.12B
Maximum
6.37B
Discovering the peaks and valleys of Amneal Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 32.48%
Maximum Annual Enterprise Value = 6.37B
Minimum Annual Increase = -59.32%
Minimum Annual Enterprise Value = 3.12B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 6.37B | 29.30% |
| 2024 | 4.93B | 32.48% |
| 2023 | 3.72B | 19.29% |
| 2022 | 3.12B | -6.65% |
| 2021 | 3.34B | 0.11% |
| 2020 | 3.34B | 2.54% |
| 2019 | 3.26B | -22.49% |
| 2018 | 4.20B | 26.38% |
| 2017 | 3.32B | -9.56% |
| 2016 | 3.67B | -59.32% |
The current Enterprise Value of Amneal Pharmaceuticals, Inc. (AMRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
5.01B
5-year avg
4.30B
10-year avg
3.93B
Amneal Pharmaceuticals, Inc.’s Enterprise Value is less than Teva Pharmaceutical Industries Limited (61.18B), less than Viatris Inc. (34.32B), less than Dr. Reddy's Laboratories Limited (1.18T), less than Bausch Health Companies Inc. (21.32B), greater than Amphastar Pharmaceuticals, Inc. (1.61B), greater than ANI Pharmaceuticals, Inc. (1.62B), greater than Perrigo Company plc (5.07B), greater than Emergent BioSolutions Inc. (785.89M), greater than Cumberland Pharmaceuticals Inc. (67.68M), greater than Indivior Pharmaceuticals Inc (4.73B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 61.18B | $47.96B | |
| 34.32B | $21.58B | |
| 1.18T | $11.74B | |
| 21.32B | $3.09B | |
| 1.61B | $1.15B | |
| 1.62B | $1.65B | |
| 5.07B | $2.18B | |
| 785.89M | $343.79M | |
| 67.68M | $66.82M | |
| 4.73B | $4.54B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amneal Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amneal Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Amneal Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 3-year average Enterprise Value for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 5-year average Enterprise Value for Amneal Pharmaceuticals, Inc. (AMRX)?
How does the current Enterprise Value for Amneal Pharmaceuticals, Inc. (AMRX) compare to its historical average?